SVR@ was achieved in @ % ( @/@ ) versus @ % ( @/@ ) of previous partial responders and @ % ( @/@ ) versus @ % ( @/@ ) of previous null responders with simeprevir and peginterferon alfa-@a and ribavirin and telaprevir and peginterferon alfa-@a and ribavirin treatment , respectively .